WEBINAR: Synergy of GLP-1's and Venus Bliss MAX™ feat. Qiana A. Johnson, DNP

Fight Muscle Loss and Loose Skin from GLP-1s with Venus Bliss MAX™: Webinar Recap

As patients increasingly turn to GLP-1 treatments for rapid weight loss, practitioners are encountering new challenges like muscle loss and loose skin. Addressing these concerns effectively is crucial for both patient satisfaction and practice success. In a recent webinar, Qiana A. Johnson, DNP, explored these issues and highlighted the benefits of incorporating Venus Bliss MAX™ into your practice.

Tackling GLP-1 Weight Loss Side Effects

The rapid weight loss achieved with GLP-1 treatments often results in muscle depletion and sagging skin. These aesthetic concerns can impact patients' confidence, making it essential to offer solutions that target them holistically. Venus Bliss MAX™ provides a 3-in-1 approach to address these challenges by:

Sculpting muscles to restore lost tone and strength

Destroying stubborn fat, even in resistant areas

Skin/Cellulite treatments, helping to improve overall body contour

This comprehensive treatment platform helps patients achieve their desired body goals and regain confidence in their appearance.

Boost Your Practice's Revenue with Membership Programs

Beyond its clinical benefits, incorporating Venus Bliss MAX™ into your practice can create new revenue opportunities. Membership programs built around this cutting-edge technology allow practices to offer patients long-term solutions instead of one-time procedures. By turning single treatments into ongoing care, you can improve patient outcomes while ensuring consistent recurring revenue for your practice.

Missed the live event? You can catch the full webinar recording below and learn how Venus Bliss MAX™ can transform both your patients' results and your practice's bottom line.

WATCH HERE!

Ready to Learn More?

If you’re looking to enhance your practice offerings with Venus Bliss MAX™, reach out today to see how this powerful device can take your practice to new heights. With proven results in fat reduction, muscle sculpting, and body contouring, Venus Bliss MAX™ is the comprehensive solution you’ve been waiting for. Contact us today!

< Older Post

Newer Post >

Venus Concept Obtains Exclusive Distribution Rights for the HIRONIC Doublo 2.0 Device in US and Canada

July 28, 2026

TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article